THE PROTECTIVE EFFECTS OF CROMAKALIM AND PINACIDIL ON REPERFUSION FUNCTION AND INFARCT SIZE IN ISOLATED PERFUSED RAT HEARTS AND ANESTHETIZED DOGS

被引:172
作者
GROVER, GJ
DZWONCZYK, S
PARHAM, CS
SLEPH, PG
机构
[1] Department of Pharmacology, Squibb Institute for Medical Research, Princeton, 08543-4000, NJ
关键词
Cromakalim; infarct size; myocardial ischemia; pinacidil;
D O I
10.1007/BF01857755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The direct myocardial protective effects of intracoronary infusions of cromakalim and pinacidil were determined in an anesthetized canine model of coronary occlusion and reperfusion. The left circumflex coronary artery was occluded for 90 minutes and reperfused for 5 hours, at which time the infarct size was determined. Cromakalim (0.1 μg/kg/min) or pinacidil (0.09 μg/kg/min) were infused into the left circumflex coronary artery starting 10 minutes preischemia. Cromakalim significantly reduced infarct size as a percent of the left ventricular area at risk (25±5%) compared with vehicle controls (55±7%). Pinacidil did not reduce infarct size at an equimolar dose, but at the higher dose also significantly reduced infarct size. Collateral blood flow was not significantly altered by either drug, though reperfusion flow was significantly higher in cromakalim-treated animals, particularly in the subepicardial region. When the same dose of cromakalim was given starting 2 minutes before the initiation of reperfusion, no significant beneficial effect of cromakalim was observed. In another study, isolated buffer-perfused rat hearts were subjected to 25 minutes of global ischemia and 30 minutes of reperfusion. These hearts were treated with 7 μM cromakalim, either starting 10 minutes before ischemia or only during reperfusion, and its effect on reperfusion function and LDH release were determined. Cromakalim pretreatment (both when given throughout the experiment and when not present in the reperfusion buffer) resulted in significant improvements in the reperfusion function. Reperfusion contracture and LDH were also significantly reduced with this treatment. When given only during reperfusion, cromakalim did not reduce the severity of ischemia when compared with vehicle controls. Thus, both cromakalim and pinacidil reduce ischemic/reperfusion injury, though the timing of treatment may be important. © 1990 Kluwer Academic Publishers.
引用
收藏
页码:465 / 474
页数:10
相关论文
共 33 条
[1]  
Weir S.W., Weston A.H., The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on<sup>86</sup>Rb<sup>+</sup> efflux in rat blood vessels, Br J Pharmacol, 88, pp. 121-128, (1986)
[2]  
Bray K.M., Newgreen D.T., Small R.C., Et al., Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea pig smooth muscle differs from that of glyceryl trinitrate, Br J Pharmacol, 91, pp. 421-429, (1987)
[3]  
Arena J.P., Dass R.S., Pinacidil, a putative K<sup>+</sup>-channel agonist, enhances K<sup>+</sup>-sensitive current in isolated guinea pig ventricular cells, Biophys J, 53, (1988)
[4]  
Osterreider W., Modification of K<sup>+</sup> conductance of heart cell membrane by BRL 34915, Naunyn Schmiedbergs Arch Pharmacol, 337, pp. 93-97, (1988)
[5]  
Grover G.J., Sleph P.G., Stranieri M., Et al., Coronary vasodilator and cardiac functional effects of the potassium channel activator cromakalim in ischemic and nonischemic rat and guinea pig hearts, The Physiologist, 31, (1988)
[6]  
Flaim S.F., Sleph P.G., Stranieri M., Et al., Effect of pinacidil on coronary flow and function in isolated perfused rat or guinea pig hearts during ischemic or nonischemic conditions, The Physiologist, 31, (1988)
[7]  
Grover G.J., McCullough J.R., Henry D.E., Et al., Antiischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide, J Pharmacol Exp Ther, 251, pp. 98-104, (1989)
[8]  
Dole W.P., Jackson D.L., Rosenblatt J.I., Et al., Relative error and variability in blood flow measurements with radio-labelled microspheres, Am J Physiol, 243, pp. H371-H378, (1982)
[9]  
Watts J.A., Maiorano L., Effects of diltiazem upon globally ischemic rat hearts, Eur J Pharmacol, 138, pp. 335-342, (1987)
[10]  
Hamm C.W., Opie L.H., Protective effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart, Circ Res, 52, pp. 129-138, (1983)